Pharmidex will attend Genesis 2025 hosted by One Nucleus
December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM), and our Dr. Ian Knowles, will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus.
They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development.
See you at Genesis 2025!
#Pharmidex #Genesis2025 #OneNucleus #DrugDiscovery #LifeSciences
Pharmidex offers a broad range of pre-clinical respiratory disease models to support drug discovery and development across multiple pulmonary indications. Our capabilities include validated models for asthma (acute, chronic and severe/exacerbation), cough, idiopathic pulmonary fibrosis (IPF), acute lung injury/ARDS, respiratory infections, COPD and allergic rhinitis. These models incorporate clinically relevant triggers and well-established positive controls, enabling robust and translational assessment of novel therapeutics. Our integrated respiratory platforms are designed to help accelerate informed decision-making from early research through to advanced pre-clinical development. If you are developing new therapies for respiratory diseases, we would be pleased to discuss how Pharmidex can support your programme. 🌐 www.pharmidex.com
At Pharmidex , we offer In Vivo (Non-GLP & GLP), In Vitro, and Organ-on-Chip toxicology, alongside our full range of non-GLP and GLP toxicology studies delivered in the UK, with quick turnaround times and UK-competitive pricing. Our experienced team supports your programme from study design through delivery, helping you generate high-quality, decision-ready data efficiently and cost-effectively. 📍 UK-based studies ⚡ Rapid timelines 💷 Competitive pricing 🧪 In Vivo (Non-GLP & GLP), In Vitro & Organ-on-Chip toxicology Learn more: www.pharmidex.com
We’re pleased to share that Martin Barrett from Pharmidex will be attending the R SC-BMCS Postgraduate Symposium XIX – Biological and Medicinal Chemistry Symposium for Postgraduates. 📅 Thursday 8th January 2026 📍 MIB Building, Manchester Martin will be presenting at the symposium and representing Pharmidex to discuss our services and capabilities in drug discovery and development. He would be delighted to meet and chat with attendees, explore new ideas, and discuss potential collaborations and partnerships. If you’re attending, please come and say hello! 🌐 www.pharmidex.com 🔗 https://www.rscbmcs.org/events/psxix/
